🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus 14mg real-world experience thread — need advice Page 2

Rybelsus 14mg real-world experience thread — need advice

Dr.EndoEP Mon, Oct 27, 2025 at 8:45 PM 9 replies 1,162 viewsPage 2 of 2
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
Oct 28, 2025 at 2:47 AM#6
MikeFit_NJ said:
Oral semaglutide is absorbed in the stomach with the help of SNAC, which locally raises pH and protects the peptide long enough to cross.

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

Ask again with the specifics and you will get a better answer than this one.

14 9EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 11 others
Reply Quote Save Share Report
Dr.RaviCardio
VIP Member
2,890
15,678
Jan 2024
New York, NY
Oct 28, 2025 at 5:09 AM#7

The figures, for anyone assembling their own picture. A quick sanity check on any figure quoted here: is it mean or median, is it intention-to-treat or completers, and what was the comparator. Three questions, and they resolve most disagreements in these threads.

13 8anna.melb_AU, mark_tokyo, hans_munich and 10 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Oct 28, 2025 at 7:30 AM#8
Dr.ObesityMed said:
I do not accept that the fasting window is a minor inconvenience.

Coming at Dr.ObesityMed’s question from a different direction. Read four things before the headline number. The population, because trial populations are selected and supported in ways that real cohorts are not. The comparator, because "better than placebo" and "better than the current standard" are different claims and get reported identically. The primary endpoint as pre-registered, because a secondary endpoint promoted after the fact is a hypothesis rather than a finding. And the completion rate, because a large effect in the half of participants who finished is a different result from a large effect in everybody enrolled.

12 7tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 9 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
paul_denver
Member
723
3,234
May 2024
Denver, CO
Oct 28, 2025 at 9:51 AM#9

One thing that is still open after Dr.DermMIA’s answer:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

Last edited: Oct 28, 2025 at 3:51 PM
11 6sarah_TO, wendy_avl, jason_paloalto and 8 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Oct 28, 2025 at 9:10 PM#10

Closing the loop on my own question.

Follow-up: moving the tablet to the moment I wake, before anything else, was the whole fix. The dose never changed.

15 15LindaRN_retired, tommy_boulder, hyun_seoul and 12 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register